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A protein family, the ‘Ov-serpins’ has been identified by comparing amino acid sequence, protein characteristics and gene organization. The 
Ov-serpins would not be recognized as a family based on sequence identity alone. This example suggests that combinations of characteristics may 
need to be examined to identify family groupings within the serpin superfamily. 
Serpin; Protease inhibitor; Protein family 
1. INTRODUCTION 
The serpins (serine protease inhibitors) and related 
proteins, constitute one of the earliest described protein 
superfamilies recognized by Hunt and Dayhoff in 198 1 
by computer analysis of amino acid sequence identity 
[l]. That seminal study revealed that the protease inhib- 
itors al-antitrypsin (al-AT) and antithrombin III 
(AT,,,) and chicken ovalbumin, which lacks protease 
inhibitory activity, are distantly related and predicted 
that the three molecules are members of different pro- 
tein families within the same superfamily [l]. In the 
present manuscript, a combination of characteristics are 
described, which strongly indicate that five serpin pro- 
teins, including ovalbumin and several recently cloned 
human proteins, belong to a single family (‘Ov-serpin 
family’). The family would not be recognized based on 
amino acid sequence identity alone, and the example 
suggests that ‘combinations of characteristics’ may be 
more appropriate as criteria for recognizing serpin 
families. 
active center region and, as mentioned above, the 
stressed configuration, which converts to a relaxed, 
more ordered configuration when cleaved within the 
reactive center loop region. Topography is thereby al- 
tered, contributing in some cases to new functions. 
Other serpins including ovalbumin [l] and angiotensin- 
ogen [4], which are not protease inhibitors, are suscepti- 
ble to proteolytic cleavage in the exposed loop region, 
but fail to undergo the stressed-to-relaxed configura- 
tional switch. At the genomic level, exon-intron borders 
of serpins generally fail to correlate with discernible 
protein domains, and intron positions vary widely 
(e.g. PI). 
3. PROTEINS OF THE OV-SERPIN FAMILY 
2. SERPIN SUPERFAMILY 
Serpins are thought to share a highly ordered tertiary 
structure defined by the crystal structure for the proto- 
type molecule al-AT and consisting of nine a-helices 
and three B-sheets arranged in a stressed configuration 
with the reactive center, the most variable region, lo- 
cated in an exposed loop where it acts as a bait for target 
protease [2,3]. Unusual features of serpin protease in- 
hibitors include extreme sequence variability of the re- 
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Molecules qualifying as Ov-serpins are ovalbumin, a 
secreted chicken oviduct protein, and gene Y, the prod- 
uct of a linked gene expressed in oviduct cells [6,7]. Gene 
Y has not been studied at the protein level. Human 
Ov-serpins include plasminogen activator-2 (PAI-2) 
formerly called placental-PA1 and monocyte-PAI. PAI- 
2 exists as a cytoplasmic non-glycosylated protein in 
unstimulated monocytes and as a secreted glycosylated 
molecule of LPS-treated monocytes [8,9]. Both the cyto- 
plasmic and secreted forms of PAI- result from transla- 
tion of one mRNA species (‘facultative polypeptide 
translocation’, [lo]). Squamous cell carcinoma antigen 
(SCCA), a recently sequenced human protein of un- 
known function, is an Ov-set-pin found within normal 
squamous epithelial cells and secreted at high levels by 
the corresponding carcinoma cells [l 11. Finally, elastase 
inhibitor (EI) an Ov-serpin found at high levels within 
human monocytes, macrophages and neutrophils, has 
been recently sequenced [ 121, as has an elastase inhibitor 
from horse leukocytes [13]. These possibly counterpart 
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molecules have 82% identity of amino acid sequence. 
The apparent counterpart of EI in guinea pigs is ex- 
pressed as both intracellular and secreted protein [14]. 
4. EXTENT OF AMINO ACID IDENTITY 
The extent of amino acid identity of Ov-serpins is 
high, 58% for the pair of chicken proteins, 4650% for 
the three human pairs, and 3946% for the six interspe- 
ties pairs (Table I). However, since the Ov-serpins also 
have considerable amino acid identity with proteins of 
the larger serpin superfamily, e.g. al-AT (30&34% iden- 
tity) and AT,,, (3340%) (Table I), this single criterion 
is inadequate for identifying family members. 
5. STRUCTURAL FEATURES 
Ov-serpins lack the N-terminal extension regions 
common to other serpins. They begin relative to al-AT 
at position 23, the first buried residue [2]. Ov-serpins 
also lack C-terminal extensions, ending with proline- 
391, the last buried residue (Fig. 1). Structural impor- 
tance is suggested for residues near proline- because 
al-AT mutants shorter by even one residue are de- 
graded in the cell [17]. The Ov-serpins have serine rather 
than asparagine as found in the larger superfamily at 
the penultimate position and a variable residue rather 
than valine at position 388 (Fig. 1). 
6. SIGNAL SEQUENCE 
Another feature distinguishing the Ov-serpins is the 
lack of a cleavable hydrophobic signal sequence com- 
monly found in the larger serpin superfamily 
[11,12,18,19]. The apparent reliance of Ov-serpins on 
non-cleavable internal signal sequences is of special in- 
terest since, as mentioned above, several Ov-serpins ap- 
Table I 
Percent identities of amino acid sequences 
El PAI-? SCCA gene Y Oval 
(human) El _ 50.2 (1) 49.9 (4) 43.0 (2) 39.9 (3) 
(human) PAI- 50.2 (1) 45.5 (5) 42.3 (3) 39.2 (4) 
(human) SCCA 49.9 (4) 45.5 (5) 46.0 (2) 42.6 (1) 
(chicken) gene Y 43.0 (2) 42.3 (3) 46.0 (2) 57.9 (1) 
(chicken) Oval 39.9 (3) 39.2 (4) 42.6 (1) 57.9 (1) 
(human) AT,,, 39.6 (6) 35.7 (7) 40.1 (6) 35.8 (6) 32.5 (6) 
(human) al-AT 30.3 (7) 31.2 (6) 33.7 (7) 29.7 (6) 29.8 (5) 
Shown are percent identical ammo actds m pairs of ahgned sequences 
with the number of gaps indicated in brackets. The comparison is 
limited to regions common to the Ov-serpin family (379 residues of El, 
378 of PAI-2, 374 m SCCA and gene Y and 372 in ovalbumin). 
Interhelical regions of PAI-2, SCCA. gene Y. ovalbumin were omttted. 
as were N- and C-terminal extenstons of al-AT and AT,,,. al-AT [15] 
and AT,,, [16]. shown for comparison, are members of the larger serpin 
superfamtly, but are not Ov-serpins. 
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pear to exist as dualistic molecules that can be either 
secreted or cytoplasmic. In the case of ovalbumin, a 
fragment was isolated corresponding to residues 239- 
282 of Fig. 1, which inhibited functional signal activity 
in an in vitro assay [20]. Examination of hybrid pro- 
teins, on the other hand, indicated that the ovalbumin 
signal sequence is located within residues 2241 (posi- 
tions 4464 in Fig. 1) [21]. 
7. INTERHELICAL REGION 
The region between helices C and D is variable in 
length and non-homologous in the superfamily and is 
accommodated in structural models as a separate loop 
that does not affect overall folding [3]. This region is 
exceptionally long (37 residues) in PAI-2, 16 residues in 
SCCA. 14 residues in ovalbumin and gene Y and is 
absent in EI (Fig. 1, enclosed box), as well as in several 
molecules of the larger serpin superfamily [3]. There is 
thus no common feature of this region that distinguishes 
the Ov-serpins as a family. 
8. GENE ORGANIZATION 
At present, at least five very different patterns of gene 
organization have been defined for serpin molecules 
[22,23]. The three Ov-serpins characterized at the 
genomic level, ovalbumin [24], gene Y [7] and PAI-2. 
have virtually identical gene organization consisting of 
seven exons and eight introns, and including identical 
splice junctions [22,25]. Since PAI- and gene Y/ovalbu- 
min have different functions and are from different spe- 
cies, their nearly identical exon-intron organization in 
the face of diverse patterns in the larger superfamily, is 
strong evidence that they belong to the same family. 
Another serpin family, consisting of the four molecules 
al-AT, cxl-antichymotrypsin, angiotensinogen. and 
heparin co-factor II/hLS2 (leuserpin 2) has also been 
identified based on a shared gene organization of five 
exons and four introns [26]. The criterion of gene organ- 
ization pattern may yet prove to be most important in 
defining serpin families. 
9. DISCUSSION 
Thus, based on extent of sequence identity, absence 
of a cleavable signal sequence, common structural fea- 
tures, and common exon-intron organization, the pro- 
teins ovalbumin, gene Y, PAI-2, EI and SCCA consti- 
tute a separate branch, or family, of the serpin superfa- 
mily as predicted by Hunt and Dayhoff.* The human 
*Recently sequenced protease inhibitors encoded by cowpox virus and 
vaccima virus have been shown to have serpin-hke sequence [27]; they 
share with Ov-serpms the properties of lacking cleavable signal se- 
quences and N-terminal extenstons. 
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Fig. 1. Comparison of proteins of the ovalbumin family of the serpin superfamily (‘Ov-serpins’). Shown are human squamous cell carcinoma ntigen 
(SCCA). human plasminogen activator-2 (PAI-2). human monocyte/neutrophil elastase inhibitor (El), chlcken ovalbumin (Oval) and chicken gene 
Y (references in text). Manual alignment and position numbers are based on the crystal structure for the prototype serpin al-AT (indicated above 
the aligned sequences) [2,3]. Shading indicates residues that are identical m 4 of 5 proteins or 3 of 3 human proteins. Also shaded are the homologous 
residues R/K or F/Y or D/E in 4 or 5 proteins. A box encloses the variable length region with minimal identities corresponding to @l-AT residues 
86-89, which forms a loop between helices C and D; it is present in four Ov-serpins, but is absent in Et The 51 dark bars indicate residues categorized 
as conserved in the larger serpm subfamily [3] and for the most part conserved in the five Ov-serpms. The exceptions are position 388 where the 
superfamily V is replaced in Ov-serpins by Y, F or C and position 390 where the subfamily N is replaced by S. Double underhnes indicate 
ovalbumin fragments with ‘signal activity’ in vitro, positions 44-64 [21] and positions 239-282 [20]. The bond corresponding to the reactive site 
is indicated by an arrow at posltions 358-359. Potential N-glycosylatlon sites, four in SCCA, three in PAI-2. five in EI, four m gene Y and two 
m ovalbumin, are encircled. 
Ov-serpins, PAI-2, EI, and SCCA merit study because 
of their likely functions in fibrinolysis, inflammation 
and neoplasia, respectively. In addition, integrated 
study of two or three of these molecules might reveal 
mechanisms that are shared, and possibly specific, to 
the Ov-serpins, such as the regulated synthesis of dualis- 
tic molecules, which can be either cytoplasmic or se- 
creted. Finally, extensive ffort is currently directed to- 
ward identifying structural features underlying the 
‘stressed-to-relaxed’ physiological switch mechanism 
unique to serpins. Since the Ov-serpins include both 
active protease inhibitor molecules (PAI- and EI) ca- 
pable of the con~gurational switch and also molecules 
lacking this capability (ovalbumin), physicochemical 
comparisons within the family might provide a uniform 
background against which to identify the structural fea- 
tures responsible for the switch mechanism. 
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